Safety and efficacy of living donor liver preservation with HTK solution.

[1]  F. Langer,et al.  Histidine–tryptophan–ketoglutarate solution for organ preservation in human liver transplantation—a prospective multi-centre observation study , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  Gerhard Rakhorst,et al.  Effect of University of Wisconsin organ-preservation solution on haemorheology , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  L. Cierpka,et al.  Organ preservation solutions impair deformability of erythrocytes in vitro. , 2003, Transplantation proceedings.

[4]  M. Malago',et al.  Histidine‐tryptophan‐ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: Results of a prospective study , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  B. Ringe,et al.  Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. , 2003, International surgery.

[6]  D. Eckhoff,et al.  Particle-induced circulatory disturbances in transplanted rhesus macaque kidneys , 2003, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  T. Fiers,et al.  Functional and structural integrity of porcine pancreatic grafts subjected to a period of warm ischemia and cold preservation with histidine-tryptophan-ketoglutarate (custodiol) or University of Wisconsin solution , 2003, Transplantation.

[8]  C. Broelsch,et al.  Celsior solution compared with University of Wisconsin solution (UW) and histidine–tryptophan–ketoglutarate solution (HTK) in the protection of human hepatocytes against ischemia–reperfusion injury , 2003, Transplant international : official journal of the European Society for Organ Transplantation.

[9]  R. Wolfe,et al.  Gender Imbalance and Outcomes in Living Donor Renal Transplantation in The United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  B. Ringe.  50: Efficiency of Recipient Screening and Donor Evaluation in Adult Living Donor Liver Transplantation , 2003 .

[11]  T. V. van Gulik,et al.  Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and celsior , 2002, Transplantation.

[12]  M. H. Vargas,et al.  Evaluation of the vascular permeability after 12-hour preservation of rabbit lungs in HTK solution. , 2002, Transplantation proceedings.

[13]  E. Schütz,et al.  A NOVEL MANAGEMENT STRATEGY OF STEROID-FREE IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION: EFFICACY AND SAFETY OF TACROLIMUS AND MYCOPHENOLATE MOFETIL , 2001, Transplantation.

[14]  R. Margreiter,et al.  Ultrastructural analysis of human endothelial cells after hypothermic storage in organ preservation solutions. , 1999, The Journal of surgical research.

[15]  B. Maes,et al.  Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. , 1998, Transplantation.

[16]  H. Shinohara,et al.  Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation. , 1997, Clinical science.

[17]  H. Shinohara,et al.  Superiority of HTK solution to UW solution for tissue oxygenation in living related liver transplantation. , 1996, Transplantation proceedings.

[18]  T. Sasaki,et al.  HTK solution is more effective than UW solution for cardiac preservation. , 1996, Transplantation proceedings.

[19]  I. Marzi,et al.  Undissolved particles in UW solution cause microcirculatory disturbances after liver transplantation in the rat , 1995, Transplant international : official journal of the European Society for Organ Transplantation.

[20]  G. Kootstra,et al.  University of Wisconsin solution is superior to histidine tryptophan ketoglutarate for preservation of ischemically damaged kidneys. , 1994, Transplantation.

[21]  E. M. Ward,et al.  Ischemic‐type biliary complications after orthotopic liver transplantation , 1992, Hepatology.

[22]  S. Thung,et al.  Initial flush solution for donor liver procurement: lactated Ringers' or UW solution? A randomized, prospective trial. , 1991, Transplantation proceedings.

[23]  P. Friend,et al.  Clinical use of UW solution or a simplified liver preservation solution prior to transplantation in 179 human livers, December 1987-July 1989. , 1990, Transplantation proceedings.

[24]  G. Klintmalm,et al.  Intraoperative evaluation of EuroCollins and University of Wisconsin preservation solutions in patients undergoing hepatic transplantation. , 1990, Transplantation.

[25]  N. Jamieson.  A new solution for liver preservation , 1989, The British journal of surgery.

[26]  R. Stratta,et al.  EXTENDED PRESERVATION OF THE LIVER FOR CLINICAL TRANSPLANTATION , 1988, The Lancet.

[27]  R. Pichlmayr,et al.  A new technique of hepatic vein reconstruction in partial liver transplantation , 1988, Transplant international : official journal of the European Society for Organ Transplantation.

[28]  G. Gubernatis,et al.  Ex situ Operation an der Leber Eine neue Möglichkeit in der Leberchirurgie , 2005, Langenbecks Archiv für Chirurgie.

[29]  P. Neuhaus,et al.  Die Leberkonservierung mit Belzer Lösung kann durch erhöhten Fluß des Konservierungsmediums im arteriellen System verbessert werden , 1992 .